Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06504030 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints revised (2)
    • Study description expanded, about 3 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is trying to evaluate the efficacy and safety of modified DEP regimens for the treatment of active hemophagocytic lymphohistiocytosis.
Trial Details
NCT Number NCT06504030
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Hemophagocytic Lymphohistiocytoses
Related terms Lymphohistiocytosis, Hemophagocytic
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov